The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Neogen Corp

Nasdaq: NEOG
Last

(U.S.) $63.37

Today's change-1.04 -1.62%
Updated January 20 4:00 PM EST. Delayed by at least 15 minutes.
 

Neogen Corp

Nasdaq: NEOG
Last

(U.S.) $63.37

Today's change-1.04 -1.62%
Updated January 20 4:00 PM EST. Delayed by at least 15 minutes.

Neogen Corp crosses below 50-day moving average

Neogen Corp closed sharply lower Friday, dropping (U.S.)$1.04 or 1.62% to (U.S.)$63.37 and crossing below its 50-day moving average. Shares have lost 4.42% for the last five days, but have gained 21.56% over the last 52 weeks. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $64.33
  • Previous close(U.S.) $64.42
  • High(U.S.) $64.43
  • Low(U.S.) $63.03
  • Bid / Ask(U.S.) $62.75 / (U.S.) $0.00
  • YTD % change-3.98%
  • Volume199,341
  • Average volume (10-day)108,664
  • Average volume (1-month)150,946
  • Average volume (3-month)142,020
  • 52-week range(U.S.) $43.79 to (U.S.) $69.09
  • Beta1.55
  • Trailing P/E61.57×
  • P/E 1 year forward55.93×
  • Forward PEG3.36×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.03
Updated January 20 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.90%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedNov 30, 201611/30/2016Aug 31, 201608/31/2016May 31, 201605/31/2016Feb 29, 201602/29/2016
Revenue91849077
Total other revenue--------
Total revenue91849077
Gross profit44404235
Total cost of revenue47434842
Total operating expense74697465
Selling / general / administrative24232421
Research & development3322
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income17151611
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax17151512
Income after tax1110108
Income tax, total6553
Net income1110108
Total adjustments to net income--------
Net income before extra. items1110108
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1110108
Inc. avail. to common incl. extra. items1110108
Diluted net income1110108
Dilution adjustment--------
Diluted weighted average shares38383838
Diluted EPS excluding extraordinary itemsvalue per share0.290.260.260.22
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.290.260.260.22